WO2007099370A3 - Tissue-adhesive formulations - Google Patents

Tissue-adhesive formulations Download PDF

Info

Publication number
WO2007099370A3
WO2007099370A3 PCT/GB2007/050090 GB2007050090W WO2007099370A3 WO 2007099370 A3 WO2007099370 A3 WO 2007099370A3 GB 2007050090 W GB2007050090 W GB 2007050090W WO 2007099370 A3 WO2007099370 A3 WO 2007099370A3
Authority
WO
WIPO (PCT)
Prior art keywords
tissue
particulate
formulation
functional groups
reactive functional
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/GB2007/050090
Other languages
French (fr)
Other versions
WO2007099370A2 (en
Inventor
Graeme Kettlewell
David John Mandley
David Harry Fortune
Ian Thompson
Diane Morris
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tissuemed Ltd
Original Assignee
Tissuemed Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB0603981A external-priority patent/GB0603981D0/en
Priority claimed from EP06270032A external-priority patent/EP1837038A1/en
Application filed by Tissuemed Ltd filed Critical Tissuemed Ltd
Priority to US12/281,289 priority Critical patent/US20090018575A1/en
Priority to EP07712973A priority patent/EP1988939A2/en
Publication of WO2007099370A2 publication Critical patent/WO2007099370A2/en
Publication of WO2007099370A3 publication Critical patent/WO2007099370A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/001—Use of materials characterised by their function or physical properties
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L24/00—Surgical adhesives or cements; Adhesives for colostomy devices
    • A61L24/04—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials
    • A61L24/06—Surgical adhesives or cements; Adhesives for colostomy devices containing macromolecular materials obtained by reactions only involving carbon-to-carbon unsaturated bonds

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Surgery (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Materials Engineering (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Materials For Medical Uses (AREA)

Abstract

A tissue-adhesive formulation comprises a particulate material having tissue- reactive functional groups, in admixture with a particulate buffer material. The formulation is preferably free or substantially free of materials of human or animal origin. In preferred embodiments, the formulation consists, or consists essentially of, an anhydrous or partially hydrated blend of particulate material having tissue- reactive functional groups and particulate buffer material. Also disclosed is a multilayer sheet comprising a structural support coated on at least one side thereof with such a tissue-adhesive formulation.
PCT/GB2007/050090 2006-03-01 2007-03-01 Tissue-adhesive formulations Ceased WO2007099370A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
US12/281,289 US20090018575A1 (en) 2006-03-01 2007-03-01 Tissue-adhesive formulations
EP07712973A EP1988939A2 (en) 2006-03-01 2007-03-01 Tissue-adhesive formulations

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
GB0603981A GB0603981D0 (en) 2006-03-01 2006-03-01 Tissue-adhesive formulations
GB0603981.2 2006-03-01
US78012406P 2006-03-08 2006-03-08
US60/780,124 2006-03-08
EP06270032A EP1837038A1 (en) 2006-03-20 2006-03-20 Tissue-Adhesive Formulations
EP06270032.3 2006-03-20

Publications (2)

Publication Number Publication Date
WO2007099370A2 WO2007099370A2 (en) 2007-09-07
WO2007099370A3 true WO2007099370A3 (en) 2008-04-03

Family

ID=38317315

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/GB2007/050090 Ceased WO2007099370A2 (en) 2006-03-01 2007-03-01 Tissue-adhesive formulations

Country Status (2)

Country Link
EP (1) EP1988939A2 (en)
WO (1) WO2007099370A2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6178399B2 (en) 2012-03-16 2017-08-09 ベンデル アナリティカル ホールディング ビー．ブイ．Ｂｅｎｄｅｒ Ａｎａｌｙｔｉｃａｌ Ｈｏｌｄｉｎｇ Ｂ．Ｖ． Crosslinked polymers derived from nucleophilically activated polyoxazolines and medical products
AU2020437820A1 (en) * 2019-12-03 2022-06-30 Massachusetts Institute Of Technology Body fluid resistant tissue adhesives

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5066709A (en) * 1990-09-20 1991-11-19 Gaf Chemicals Corporation Bioadhesive composition
WO2000038752A1 (en) * 1998-12-23 2000-07-06 Aventis Behring Gmbh Fibrin-based glue granulate and corresponding production method
WO2004087227A1 (en) * 2003-04-04 2004-10-14 Tissuemed Limited Tissue-adhesive formulations

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5066709A (en) * 1990-09-20 1991-11-19 Gaf Chemicals Corporation Bioadhesive composition
WO2000038752A1 (en) * 1998-12-23 2000-07-06 Aventis Behring Gmbh Fibrin-based glue granulate and corresponding production method
WO2004087227A1 (en) * 2003-04-04 2004-10-14 Tissuemed Limited Tissue-adhesive formulations

Also Published As

Publication number Publication date
WO2007099370A2 (en) 2007-09-07
EP1988939A2 (en) 2008-11-12

Similar Documents

Publication Publication Date Title
AU2001233314A1 (en) Polymeric blends and composites and laminates thereof
WO2006014626A3 (en) Partuculate constructs for release of active agents
EP1944277A4 (en) ANTIBUED ARTICLE AND ANTIBED AGENT COMPOSITION
BRPI0717190A2 (en) "ABSORBENT ARTICLE AND COMPOSITE SHEET"
ATE455563T1 (en) COMPOSITIONS FOR TISSUE ADHESION
EP1839630A3 (en) Drapeable absorbant article
WO2006097535A3 (en) Peptide agonists of the glucagon family with secretin like activity
EP1637109A3 (en) Body attachable drapeable sanitary absorbant napkin
ZA200607343B (en) Antifoullng coating composition and its use on man made structures
EP1839631A3 (en) Drapeable absorbent article
AU2003239484A1 (en) Zooplankton enrichment with probionts and prebionts and uses thereof
WO2005065456A3 (en) Active substance combinations having insecticidal properties
IL192611A0 (en) Biologically active composition comprising ethylcellulose
AU2003253987A1 (en) Superabsorbent materials with low gel-bed friction angles and composites made from the same
FR2881432B1 (en) RUBBER COMPOSITION AND PNEUMATIC BANDAGE USING THE SAME
AU2003218359A1 (en) Polymer composition and dosage forms comprising the same
BRPI0515370B8 (en) sanitary napkin
AU2002368319A1 (en) Chemically amplified polymer having pendant group with dicyclohexyl and resist composition comprising the same
FR2888748B1 (en) NEUROPROTECTIVE COMPOUNDS AND PHARMACEUTICAL COMPOSITIONS COMPRISING THE SAME
WO2008029331A3 (en) Absorbent articles with elasticated topsheet with reduced leakage
WO2003037219A3 (en) Use of chitosan materials
EP1371690A3 (en) Polymeric nanoparticle formulations and their use in microbe repellent coatings
AU2003250881A1 (en) Polymeric blends and use thereof
AU2003228305A1 (en) Pharmaceutical composition with combined active agents and methods for using the same
AU2003242070A1 (en) Anti-pharyngolaryngitis composition with igy and its agent

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 07712973

Country of ref document: EP

Kind code of ref document: A2

DPE1 Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2007712973

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 12281289

Country of ref document: US

NENP Non-entry into the national phase

Ref country code: DE